查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040382

流感疫苗市場規模、佔有率和趨勢分析報告：按疫苗類型、適應症、年齡層、給藥途徑、分銷管道、地區和細分市場預測（2026-2033 年）

Influenza Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type, By Indication, By Age Group, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

流感疫苗市場概覽

2025年全球流感疫苗市場規模估計為89.2413億美元，預計2033年將達到147.9735億美元。

預計2026年至2033年，流感疫苗市場將以6.51%的複合年成長率成長。由於季節性流感發病率上升以及疫苗接種建議的加強，預計流感疫苗的銷售量將在整個預測期內持續成長。

根據世界衛生組織預測，到2026年初，流感病例將顯著增加，美國將經歷一個嚴重的流感季，預計將有超過1500萬例病例、18萬例住院病例和7400例死亡病例。美國疾病管制與預防中心（CDC）在2023年10月發布的一項估計顯示，全球季節性流感病例將接近10億例，其中約有300萬至500萬例出現併發症。此外，加強國家和全球監測系統以及擴大政府對疫苗分發、供應和接種的支持，是推動流感疫苗產業成長要素。

全球流感疫苗產業在後疫情時代持續穩定成長，這得益於大眾對呼吸道感染疾病的認知不斷提高以及年度免疫接種計畫的建立。儘管新冠疫情期間的感染高峰已經消退，但意識提升和機構準備工作的加強使得多個國家的疫苗接種率保持在疫情前水平以上。根據美國疾病管制與預防中心（CDC）預測，2023-2024流感季美國預計將出現2800萬至3500萬例感染、31萬至39萬例住院治療以及2萬至2.5萬例死亡，這凸顯了流感疾病持續帶來的沉重負擔以及疫苗接種的關鍵作用。

創新仍然是流感疫苗市場的主要成長要素，尤其是在下一代疫苗和聯合疫苗的研發方面。各公司正在增加對基於mRNA和重組技術的投資，以提高疫苗效力並縮短生產週期。例如，2023年10月，Moderna公司公佈了其mRNA-1083聯合疫苗的積極I/II期臨床試驗數據，該疫苗同時針對新冠病毒和流感病毒，顯示出對多種病毒株的強效免疫反應。此外，輝瑞和BioNTech公司也持續推進其以mRNA為基礎的流感疫苗和聯合疫苗候選產品，計畫於2024年進入中期臨床試驗階段。

強力的監管支持和不斷完善的全球免疫指南為這個市場提供了支撐。世界衛生組織（世衛組織）等機構持續更新其半年一次的株組成建議，以確保疫苗對流行變種的有效性。 2024年，世衛組織強調將更新的甲型流感（H1N1和H3N2）和乙型流感株納入季節性疫苗。世界各國政府也正在加強疫苗儲備策略和公共疫苗接種宣傳活動，以減輕季節性疫情爆發以及與其他呼吸道病毒的潛在合併感染。

目錄

第1章：流感疫苗市場：調查方法與範圍

第2章：流感疫苗市場：執行摘要

  • 市場概覽
  • 疫苗類型概述
  • 適應症概述
  • 按年齡層別概覽
  • 管理路線概述
  • 通路概覽
  • 競爭格局概述

第3章：流感疫苗市場：影響因素、趨勢與範圍

  • 市場區隔和範圍
  • 市場譜系展望
  • 市場動態
  • 波特五力分析
  • PESTEL 分析
  • 管道分析

第4章：流感疫苗市場：依疫苗類型分類的估算與趨勢分析

  • 全球流感疫苗市場：按疫苗類型分類的概覽
  • 全球流感疫苗市場：按疫苗類型分類的波動分析
  • 全球流感疫苗市場：依疫苗類型和銷售收入分類
  • 去活化疫苗
  • 減毒活疫苗

第5章：流感疫苗市場：依適應症分類的估算與趨勢分析

  • 全球流感疫苗市場：按適應症分類的概覽
  • 全球流感疫苗市場：按適應症分類的波動分析
  • 全球流感疫苗市場：依適應症和銷售收入分類
  • 四價
  • 三價

第6章：流感疫苗市場：依年齡層別分類的估算與趨勢分析

  • 全球流感疫苗市場：基於年齡的概覽
  • 全球流感疫苗市場：基於年齡的波動分析
  • 全球流感疫苗市場：依年齡層和銷售收入分類
  • 兒童
  • 成人

第7章：流感疫苗市場：依給藥途徑分類的估算與趨勢分析

  • 全球流感疫苗市場：按給藥途徑分類的概覽
  • 全球流感疫苗市場：按給藥途徑分類的波動分析
  • 全球流感疫苗市場：依給藥途徑及銷售收入分類。
  • 注射
  • 鼻噴霧

第8章：流感疫苗市場：按分銷管道分類的估算和趨勢分析

  • 全球流感疫苗市場：通路概覽
  • 全球流感疫苗市場：按分銷管道分類的波動分析
  • 全球流感疫苗市場：依通路及銷售收入分類
  • 醫院和藥房
  • 為政府和機構提供物資
  • 其他

第9章：流感疫苗市場：區域預測與趨勢分析

  • 區域儀錶板
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 主要市場參與企業的最新趨勢及影響分析
  • 公司和競爭對手的分類
  • 供應商情況
    • 主要銷售代理商和通路夥伴名單
    • 主要公司市佔率分析（2025 年）
    • GSK plc
    • Pfizer Inc
    • Sanofi
    • Vaxess Technologies Inc
    • Merck & Co., Inc.
    • Viatris Inc.
    • OSIVAX
    • AstraZeneca
    • SINOVAC
    • CSL Limited
    • EMERGENT
    • EMERGEX VACCINES
Product Code: GVR-4-68040-019-6

Influenza Vaccine Market Summary

The global influenza vaccine market size was estimated at USD 8,924.13 million in 2025 and is projected to reach USD 14,797.35 million by 2033, growing at a CAGR of 6.51% from 2026 to 2033. The influenza vaccine sales are expected to increase throughout the forecast period due to an increase in the incidence of seasonal flu and increased recommendations for vaccination against the disease.

According to the WHO, influenza cases have significantly increased as of early 2026, with the US experiencing a severe season, with estimates of over 15 million cases, 180,000 hospitalizations, and 7,400 deaths.According to the CDC's estimates published in October 2023, nearly one billion cases of seasonal influenza are reported globally, including around 3-5 million cases with complications. In addition, a surge in surveillance and government support for vaccination at the country and global levels to monitor vaccine distribution, supply, and administration is one of the growth drivers for the influenza vaccine industry.

The global influenza vaccine industry continues to demonstrate stable and essential growth in the post-pandemic period, supported by sustained awareness of respiratory infectious diseases and the normalization of annual immunization programs. While the surge witnessed during COVID-19 has moderated, vaccination uptake remains higher than pre-pandemic levels in several countries, driven by improved public health awareness and institutional preparedness. According to the CDC, the 2023-2024 influenza season resulted in an estimated 28-35 million illnesses, 310,000-390,000 hospitalizations, and 20,000-25,000 deaths in the U.S., highlighting the continued burden of disease and the critical role of vaccination.

Innovation remains a key growth driver in the influenza vaccine market, particularly with the advancement of next-generation and combination vaccines. Companies are increasingly investing in mRNA-based and recombinant technologies to enhance vaccine efficacy and reduce production timelines. For instance, in October 2023, Moderna, Inc. announced positive Phase 1/2 data for its mRNA-1083 combination vaccine targeting both COVID-19 and influenza, demonstrating a strong immune response against multiple strains. Additionally, Pfizer and BioNTech continued progressing their mRNA-based influenza and combination vaccine candidates into mid-stage clinical trials in 2024.

The market is supported by strong regulatory backing and expanding immunization guidelines globally. Organizations such as the World Health Organization (WHO) continue to update biannual recommendations on strain composition, ensuring vaccine effectiveness against circulating variants. In 2024, the WHO emphasized the inclusion of updated influenza A (H1N1 and H3N2) and influenza B strains in seasonal vaccines. Governments worldwide are also strengthening stockpiling strategies and public vaccination campaigns to mitigate seasonal outbreaks and potential co-infections with other respiratory viruses.

Global Influenza Vaccine Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global influenza vaccine market report based on vaccine type, indication, age group,route of administration, distribution channel, and region:

  • Vaccine Type Outlook (USD Million, 2021 - 2033)
  • Inactivated
  • Live Attenuated
  • Indication Outlook (USD Million; 2021 - 2033)
  • Quadrivalent
  • Trivalent
  • Age Group Outlook (USD Million; 2021 - 2033)
  • Pediatric
  • Adults
  • Route of Administration Outlook (USD Million; 2021 - 2033)
  • Injection
  • Nasal Spray
  • Distribution Channel Outlook (USD Million; 2021 - 2033)
  • Hospitals & pharmacy
  • Government & Institutional Supply
  • Other
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Influenza Vaccine Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Vaccine Type Segment
      • 1.1.1.2. Indication Segment
      • 1.1.1.3. Age Group Segment
      • 1.1.1.4. Route of Administration Segment
      • 1.1.1.5. Distribution Channel Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Influenza Vaccine Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Vaccine Type Snapshot
  • 2.3. Indication Snapshot
  • 2.4. Age Group Snapshot
  • 2.5. Route of Administration Snapshot
  • 2.6. Distribution Channel Snapshot
  • 2.7. Competitive Landscape Snapshot

Chapter 3. Influenza Vaccine Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Porter's Five Forces Analysis
  • 3.5. PESTLE Analysis
  • 3.6. Pipeline Analysis

Chapter 4. Influenza Vaccine Market: Vaccine Type Estimates & Trend Analysis

  • 4.1. Global Influenza Vaccine Market: Vaccine Type Dashboard
  • 4.2. Global Influenza Vaccine Market: Vaccine Type Movement Analysis
  • 4.3. Global Influenza Vaccine Market by vaccine type, Revenue
  • 4.4. Inactivated
    • 4.4.1. Inactivated market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Live Attenuated
    • 4.5.1. Live Attenuated market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Influenza Vaccine Market: Indication Estimates & Trend Analysis

  • 5.1. Global Influenza Vaccine Market: Indication Dashboard
  • 5.2. Global Influenza Vaccine Market: Indication Movement Analysis
  • 5.3. Global Influenza Vaccine Market by Indication, Revenue
  • 5.4. Quadrivalent
    • 5.4.1. Quadrivalent market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Trivalent
    • 5.5.1. Trivalent market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Influenza Vaccine Market: Age Group Estimates & Trend Analysis

  • 6.1. Global Influenza Vaccine Market: Age Group Dashboard
  • 6.2. Global Influenza Vaccine Market: Age Group Movement Analysis
  • 6.3. Global Influenza Vaccine Market by Age Group, Revenue
  • 6.4. Pediatric
    • 6.4.1. Pediatric market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Adults
    • 6.5.1. Adults market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Influenza Vaccine Market: Route of Administration Estimates & Trend Analysis

  • 7.1. Global Influenza Vaccine Market: Route of Administration Dashboard
  • 7.2. Global Influenza Vaccine Market: Route of Administration Movement Analysis
  • 7.3. Global Influenza Vaccine Market by Route of Administration, Revenue
  • 7.4. Injection
    • 7.4.1. Injection market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Nasal Spray
    • 7.5.1. Nasal Spray market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Influenza Vaccine Market: Distribution Channel Estimates & Trend Analysis

  • 8.1. Global Influenza Vaccine Market: Distribution Channel Dashboard
  • 8.2. Global Influenza Vaccine Market: Distribution Channel Movement Analysis
  • 8.3. Global Influenza Vaccine Market by Distribution Channel, Revenue
  • 8.4. Hospitals & pharmacy
    • 8.4.1. Hospitals & pharmacy market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Government & Institutional Supply
    • 8.5.1. Government & Institutional Supply market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6. Other
    • 8.6.1. Other market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Influenza Vaccine Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 9.3. North America
    • 9.3.1. U.S.
      • 9.3.1.1. Key country dynamics
      • 9.3.1.2. Regulatory framework/ reimbursement structure
      • 9.3.1.3. Competitive scenario
      • 9.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.3.2. Canada
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework/ reimbursement structure
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.3.3. Mexico
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework/ reimbursement structure
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework/ reimbursement structure
      • 9.4.1.3. Competitive scenario
      • 9.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework/ reimbursement structure
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework/ reimbursement structure
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework/ reimbursement structure
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework/ reimbursement structure
      • 9.4.5.3. Competitive scenario
      • 9.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.6. Norway
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework/ reimbursement structure
      • 9.4.6.3. Competitive scenario
      • 9.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework/ reimbursement structure
      • 9.4.7.3. Competitive scenario
      • 9.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.4.8. Denmark
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Regulatory framework/ reimbursement structure
      • 9.4.8.3. Competitive scenario
      • 9.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.2. China
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.3. India
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.4. Australia
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework/ reimbursement structure
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework/ reimbursement structure
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework/ reimbursement structure
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Key company market share analysis, 2025
    • 10.3.4. GSK plc
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Pfizer Inc
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Sanofi
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Vaxess Technologies Inc
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Merck & Co., Inc.
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Viatris Inc.
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. OSIVAX
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. AstraZeneca
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Product benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. SINOVAC
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Product benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. CSL Limited
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Product benchmarking
      • 10.3.13.4. Strategic initiatives
    • 10.3.14. EMERGENT
      • 10.3.14.1. Company overview
      • 10.3.14.2. Financial performance
      • 10.3.14.3. Product benchmarking
      • 10.3.14.4. Strategic initiatives
    • 10.3.15. EMERGEX VACCINES
      • 10.3.15.1. Company overview
      • 10.3.15.2. Financial performance
      • 10.3.15.3. Product benchmarking
      • 10.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Influenza Vaccine Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 5 Global Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 6 Global Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 7 Global Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 8 Global Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 9 North America Influenza Vaccine Market, By Country, 2021 - 2033 (USD Million)
  • Table 10 North America Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 11 North America Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 12 North America Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 13 North America Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 14 North America Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 15 U.S. Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 16 U.S. Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 17 U.S. Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 18 U.S. Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 19 U.S. Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 20 Canada Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 21 Canada Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 22 Canada Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 23 Canada Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 24 Canada Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 25 Mexico Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 26 Mexico Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 27 Mexico Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 28 Mexico Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 29 Mexico Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 30 Europe Influenza Vaccine Market, By Country, 2021 - 2033 (USD Million)
  • Table 31 Europe Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 32 Europe Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 33 Europe Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 34 Europe Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 35 Europe Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 36 Germany Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 37 Germany Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 38 Germany Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 39 Germany Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 40 Germany Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 41 UK Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 42 UK Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 43 UK Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 44 UK Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 45 UK Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 46 Spain Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 47 Spain Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 48 Spain Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 49 Spain Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 50 Spain Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 51 France Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 52 France Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 53 France Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 54 France Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 55 France Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 56 Italy Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 57 Italy Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 58 Italy Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 59 Italy Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 60 Italy Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 61 Sweden Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 62 Sweden Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 63 Sweden Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 64 Sweden Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 65 Sweden Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 66 Norway Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 67 Norway Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 68 Norway Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 69 Norway Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 70 Norway Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 71 Denmark Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 72 Denmark Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 73 Denmark Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 74 Denmark Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 75 Denmark Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 76 Asia Pacific Influenza Vaccine Market, By Country, 2021 - 2033 (USD Million)
  • Table 77 Asia Pacific Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 78 Asia Pacific Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 79 Asia Pacific Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 80 Asia Pacific Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 81 Asia Pacific Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 82 Japan Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 83 Japan Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 84 Japan Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 85 Japan Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 86 Japan Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 87 China Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 88 China Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 89 China Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 90 China Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 91 China Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 92 India Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 93 India Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 94 India Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 95 India Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 96 India Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 97 South Korea Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 98 South Korea Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 99 South Korea Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 100 South Korea Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 101 South Korea Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 102 Australia Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 103 Australia Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 104 Australia Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 105 Australia Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 106 Australia Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 107 Thailand Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 108 Thailand Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 109 Thailand Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 110 Thailand Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 111 Thailand Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 112 Latin America Influenza Vaccine Market, By Country, 2021 - 2033 (USD Million)
  • Table 113 Latin America Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 114 Latin America Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 115 Latin America Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 116 Latin America Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 117 Latin America Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 118 Brazil Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 119 Brazil Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 120 Brazil Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 121 Brazil Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 122 Brazil Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 123 Argentina Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 124 Argentina Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 125 Argentina Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 126 Argentina Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 127 Argentina Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 128 MEA Influenza Vaccine Market, By Country, 2021 - 2033 (USD Million)
  • Table 129 MEA Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 130 MEA Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 131 MEA Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 132 MEA Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 133 MEA Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 134 South Africa Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 135 South Africa Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 136 South Africa Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 137 South Africa Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 138 South Africa Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 139 Saudi Arabia Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 140 Saudi Arabia Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 141 Saudi Arabia Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 142 Saudi Arabia Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 143 Saudi Arabia Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 144 UAE Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 145 UAE Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 146 UAE Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 147 UAE Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 148 UAE Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 149 Kuwait Influenza Vaccine Market, By Vaccine Type, 2021 - 2033 (USD Million)
  • Table 150 Kuwait Influenza Vaccine Market, By Indication, 2021 - 2033 (USD Million)
  • Table 151 Kuwait Influenza Vaccine Market, By Age Group, 2021 - 2033 (USD Million)
  • Table 152 Kuwait Influenza Vaccine Market, By Route of Administration, 2021 - 2033 (USD Million)
  • Table 153 Kuwait Influenza Vaccine Market, By Distribution Channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Influenza Vaccine Market Segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment.
  • Fig. 8 Market formulation & validation
  • Fig. 9 Influenza vaccine market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Influenza vaccine market: Vaccine Type movement analysis
  • Fig. 14 Influenza vaccine market: Vaccine Type outlook and key takeaways
  • Fig. 15 Inactivated market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Live Attenuated estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Influenza vaccine market: Indication movement analysis
  • Fig. 18 Influenza vaccine market: Indication outlook and key takeaways
  • Fig. 19 Quadrivalent market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Trivalent estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Influenza vaccine market: Age Group movement analysis
  • Fig. 22 Influenza vaccine market: Age Group outlook and key takeaways
  • Fig. 23 Pediatric estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Adults market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Influenza vaccine market: Route of Administration movement analysis
  • Fig. 26 Influenza vaccine market: Route of Administration outlook and key takeaways
  • Fig. 27 Injection estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Nasal Spray market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Influenza vaccine market: Distribution Channel movement analysis
  • Fig. 30 Influenza vaccine market: Distribution Channel outlook and key takeaways
  • Fig. 31 Hospitals & pharmacy market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Government & Institutional Supply market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Other market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Global influenza vaccine market: Regional movement analysis
  • Fig. 35 Global influenza vaccine market: Regional outlook and key takeaways
  • Fig. 36 Global influenza vaccine market share and leading players
  • Fig. 37 North America, by country
  • Fig. 38 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. key country dynamics
  • Fig. 40 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Canada key country dynamics
  • Fig. 42 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Mexico key country dynamics
  • Fig. 44 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 UK key country dynamics
  • Fig. 47 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Germany key country dynamics
  • Fig. 49 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 France key country dynamics
  • Fig. 51 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Italy key country dynamics
  • Fig. 53 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Spain key country dynamics
  • Fig. 55 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Denmark key country dynamics
  • Fig. 57 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden key country dynamics
  • Fig. 59 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Norway key country dynamics
  • Fig. 61 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 China key country dynamics
  • Fig. 64 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Japan key country dynamics
  • Fig. 66 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 India key country dynamics
  • Fig. 68 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Thailand key country dynamics
  • Fig. 70 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 South Korea key country dynamics
  • Fig. 72 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Australia key country dynamics
  • Fig. 74 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Brazil key country dynamics
  • Fig. 77 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Argentina key country dynamics
  • Fig. 79 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Middle East & Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 South Africa key country dynamics
  • Fig. 82 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Saudi Arabia key country dynamics
  • Fig. 84 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 UAE key country dynamics
  • Fig. 86 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Kuwait key country dynamics
  • Fig. 88 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Market share of key market players- Influenza vaccine market